Antimicrobial studies on three Hypericum species from Turkey  by Dulger, B. et al.




South African Journal of Botany 2005, 71(1): 100–103
Printed in South Africa — All rights reserved
Short Communication
Antimicrobial studies on three Hypericum species from Turkey
B Dulger1*, A Gonuz1 and S Bilen2
1 Department of Biology, Faculty of Science and Arts, Çanakkale Onsekiz Mart University, Canakkale, Turkey
2 Faculty of Fisheries, Çanakkale Onsekiz Mart University, Çanakkale, Turkey
* Corresponding author, e-mail: dbasaran@comu.edu.tr
Received 28 April 2004, accepted in revised form 8 June 2004
The antimicrobial activity of several extracts and
fractions of some Hypericum species (H. rupestre Jaub.
& Spach, H. vacciniifolium Hayek & Siehe and H.
imbricatum Poulter) was investigated using the disc
diffusion method against Escherichia coli ATCC 11230,
Staphylococcus aureus ATCC 6538P, Klebsiella
pneumoniae UC57, Micrococcus luteus La 2971,
Bordetella bronchiseptica ATCC 19395, Proteus
vulgaris ATCC 8427, Pseudomonas aeruginosa ATCC
27853, Corynebacterium xerosis CCM 7064,
Mycobacterium smegmatis CCM 2067, Bacillus subtilis
ATCC 6633, Aeromonas hydrophila ATCC 49803,
Candida albicans ATCC 10231, Saccharomyces
cerevisiae ATCC 9730, Kluyveromyces fragilis NRRL
2415 and Rhodotorula rubra CCY. The methanol extract
and chloroform fraction of H. vacciniifolium, as well as
the methanol extracts, butanol and chloroform fractions
of both H. rupestre and H. imbricatum, showed good
antimicrobial activity against especially Gram-positive
bacteria and the Gram-negative bacterium Bordetella
bronchiseptica. The methanol extracts and fractions did
not have antifungal activity. The results of the study
support the use of these specimens in Turkish
traditional medicine to treat skin and eye infections.
Medicinal plants have for centuries constituted an important
source of active bio-molecules. Although medicinal plants’
potential in Turkey is quite large, ethnobotanical and
pharmaceutical studies on these plants are inadequate.
Hypericum has been used for centuries in the treatment of
burns, bruises, swelling, inflammation and anxiety, as well
as bacterial and viral infections (Baytop 1999, Ozturk et al.
2002). One of the most important species of this genus is
Hypericum perforatum L. which has been used in herbal
medicine externally for the treatment of skin wounds,
eczema and burns, and internally for diseases of the central
nervous system, the alimentary tract and others (Rabanal et
al. 2002).
The Hypericum species (H. rupestre Jaub. & Spach, H.
vacciniifolium Hayek & Siehe and H. imbricatum Poulter)
used in this study are endemic to Turkey and the Euro-
Siberian area. Although other species of Hypericum have
been found to exert antidepressant, antimicrobial and
wound-healing effects (Sakar and Tamer 1990, Sokmen et
al. 1999, Pistelli et al. 2000, Schwob et al. 2002, Couladis et
al. 2003, Mukherjee et al. 2003), there is no ethnobotanical
information on these species. However, it was determined
that the Hypericum species used in this study have been
used for opthalmia, eczema, swelling, bruises and wounds
during our field studies. In this study, our aim was to
determine the antimicrobial effects of plant extracts obtained
from three endemic Hypericum L. species against micro-
organisms. Further investigations on Hypericum L. species
are necessary to provide additional knowledge about these
plants.
Three species of Hypericum (H. rupestre Jaub. & Spach,
H. vacciniifolium Hayek & Siehe and H. imbricatum Poulter)
were collected from Icel, Turkey, during the months of
September–October of 2001. Voucher specimens of the
plants (AG 346, AG 474 and AG 302, respectively) were
deposited in the Biology Department at Canakkale Onsekiz
Mart University, Canakkale, Turkey.
Escherichia coli ATCC 11230, Staphylococcus aureus
ATCC 6538P, Klebsiella pneumoniae UC57, Micrococcus
luteus La 2971, 7, Bordetella bronchiseptica ATCC 19395,
Proteus vulgaris ATCC 8427, Pseudomonas aeruginosa
ATCC 27853, Corynebacterium xerosis CCM 7064,
Mycobacterium smegmatis CCM 2067, Bacillus subtilis
ATCC 6633, Aeromonas hydrophila ATCC 49803, Candida
albicans ATCC 10231, Saccharomyces cerevisiae ATCC
9730, Kluyveromyces fragilis NRRL 2415 and Rhodotorula
rubra CCY were maintained in the Laboratory of Basic and
Industrial Microbiology, Aegean University.
The aerial parts of the plants were dried in an oven at
40°C (12h) and powdered. The methanol extracts were
obtained by maceration of the plant material with methanol
for 3 days at room temperature, and this procedure was
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repeated three times. The respective extracts were filtered
and dried under reduced pressure at a temperature below
45°C. Then, with the methanol extract, a distribution
between chloroform/water (CHCl3/H2O) was made and the
chloroform and aqueous fractions obtained. Finally, the
aqueous fraction was again subjected to a partitioning
between n-butanol/water (n-BuOH/H2O). The yield obtained
for each extract and fraction with respect to the initial dry
material were H. rupestre: 18.20% for MeOH (CHCl3 7.79%,
BuOH 24.42%, aqueous 34.52%); H. vacciniifolium: 24.30%
for MeOH (CHCl3 15.29%, BuOH 18.75%, aqueous
42.80%); H. imbricatum: 21.95% for MeOH (CHCl3 28.24%,
BuOH 32.14%, aqueous 22.82%).
Infusion was prepared with 100g of crude powder and
1 000ml of water, and the volume was adjusted to a
concentration of 1g ml–1 under reduced pressure and at
40°C.
The different extracts and fractions were diluted in
dimethylsulfoxide (DMSO). The corresponding
concentrations are expressed in terms of mg of extract or
fraction per ml of solvent, with the exception of the infusion
whose concentration is expressed in terms of mg ml–1 of
initial dry material.
The antimicrobial studies were carried out by the disc
diffusion method (Bauer et al. 1966). The micro-organisms
to be tested were inoculated into Brain Heart Infusion Agar
(Oxoid) for the bacteria, and Sabouraud Dextrose Agar
(Oxoid) for the yeasts. After an incubation period of 24h at
35°C and 28°C, respectively, three or four colonies isolated
from the media were inoculated into 4ml of Brain Heart
Infusion Broth (Oxoid) for the bacteria and Sabouraud
Dextrose Broth (Oxoid) for the yeasts and incubated for 2h
at 35°C and 28°C, respectively. The cultures were adjusted
with sterile saline solution to obtain a turbidity comparable to
that of McFarland 0.5 standard. Petri dishes containing
Mueller-Hinton Agar (Oxoid) or Bacto Yeast Morphology
Agar (Difco) were impregnated with these microbial
suspensions for the bacteria and the yeasts, respectively
(Bauer et al. 1966, Jones et al. 1987, Rabanal et al. 2002).
Three concentrations were prepared for each extract and
fraction: 125mg ml–1, 250mg ml–1 and 375mg ml–1 and blank
discs of 6mm diameter (Schleicher & Schull No 2668,
Germany) were impregnated with 10µl of each (final doses
obtained per disc: 1.25mg, 2.50mg and 3.75mg). The
infusion were assayed at two concentrations: 1g ml–1 and
0.5g ml–1 (10mg and 5mg per disc, respectively). Blank discs
impregnated with DMSO were used as negative controls.
The plates were incubated overnight at 37°C (bacteria) and
28–30°C (fungi). At the end of the period, inhibition zones
formed on the medium were evaluated in mm (including
diameter of the disc (6.0mm)). Studies were performed in
triplicate. On each plate an appropriate reference antibiotic
disc was applied depending on the test micro-organisms.
Table 1 gives a summary of the antimicrobial activity by
the disc diffusion method of H. rupestre, H. vacciniifolium
and H. imbricatum methanol extracts. No activity was found
against Escherichia coli, Klebsiella pneumoniae and Proteus
vulgaris and the yeast cultures. In contrast, different results
were obtained against Stapylococcus aureus, Micrococcus
luteus, Bacillus subtilis, Bordetella bronchiseptica,
Pseudomonas aeruginosa, Corynebacterium xerosis,
Aeromonas hydrophila and acid-fast bacterium
Mycobacterium smegmatis. The diameters of growth
inhibition zones of extracts studied were in the range
12–22mm.
Antimicrobial activities of the aqueous, butanol and
chloroform fractions obtained from the methanol extracts of
the three Hypericum species are given in Table 2. The
aqueous fraction of the three species as well as the butanol
fraction of H. vacciniifolium showed no antimicrobial activity
at all. The diameter of growth inhibition area by the extracts
was in the range 10–20mm.
It could be observed in Table 1 and Table 2 that methanol
extracts of the three Hypericum species have higher
antimicrobial effect than those of the standard antibiotics
P10, SAM20, CTX30 and VA30 against Staphylococcus
aureus. When the results obtained with the methanol
extracts were compared to those of some standard
antibiotics, it was determined that Bordetella bronchiseptica,
Pseudomonas aeruginosa, Corynebacterium xerosis and
Bacillus subtilis are more susceptible compared to some of
the standard references. Micrococcus luteus is more
resistant as compared to some of the standard antibiotics.
Similarly, acid-fast bacterium Mycobacterium smegmatis
was more susceptible to the methanol extracts, as
compared to P10 and CTX30 standard antibiotics.
As can be seen from Table 2, the most significant activity
among Hypericum species was observed with the
chloroform fraction from Hypericum imbricatum, which
showed inhibition values close to those of some standard
antibiotics. This fraction of H. imbricatum was found to show
the highest activity against Bacillus subtilis. This situation
provides a support to the traditional use of Hypericum
imbricatum for treatment of eye infections. It is worth noting
that in the case of Hypericum vacciniifolium, only the
chloroform fraction conserved the antimicrobial effect,
suggesting that the active compounds are concentrated in it.
In general, Gram-negative bacteria have been found to be
more resistant to extracts (except for Bordetella
bronchiseptica) than Gram-positive bacteria in this study,
possibly because of their cell wall lipolysaccharides.
Rabanal et al. (2002) reported that the extracts of three
species of Hypericum (H. canariense, H. glondulosum and
H. grandifolium) showed antibacterial activity against the
Gram-positive bacteria Bacillus cereus var. mycoides,
Micrococcus luteus, Staphylococcus aureus and
Staphylococcus epidermidis and Gram-negative bacterium
Bordetella bronchiseptica, but no antifungal activity was
seen. In addition, the chloroform fraction was found to be very
effective against the tested micro-organisms. The findings
obtained from this study are similar to those stated above.
In summary, the three Hypericum species used in this
study showed good antimicrobial activity especially against
Gram-positive bacteria such as Staphylococcus aureus and
Bacillus subtilis. This situation provides a support to the use
of these species in traditional medicine for treating skin
diseases such as infected wounds and abscesses and eye
infections. Further phytochemical studies are required to
determine the types of compounds responsible for the
antimicrobial activities of these medicinal plants.
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Table 1: Inhibitory activity of methanolic extracts from Hypericum species in the disc diffusion assay
Extract Dose (mg/disc) Diameter of inhibition zone (mm)
1a 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Hypericum rupestre 1.25 – 18 – 16 17 – 12 12 16 14 16 – – – –
MeOH extract 2.50 – 20 – 16 18 – 13 14 18 16 18 – – – –
3.75 – 21 – 16 18 – 13 16 19 16 18 – – – –
Hypericum vacciniifolium 1.25 – 17 – 13 14 – 13 12 14 14 16 – – – –
MeOH extract 2.50 – 18 – 14 14 – 13 12 15 14 16 – – – –
3.75 – 20 – 14 14 – 14 12 15 14 16 – – – –
Hypericum imbricatum 1.25 – 18 – 14 14 – 12 12 14 14 14 – – – –
MeOH extract 2.50 – 21 – 14 15 – 12 14 14 14 16 – – – –
3.75 – 22 – 14 16 – 12 14 14 14 16 – – – –
DMSO (control) – – – – – – – – – – – – – – –
a 1: Escherichia coli, 2: Staphylococcus aureus, 3: Klebsiella pneumoniae, 4: Micrococcus luteus, 5: Bordetella bronchiseptica, 6: Proteus
vulgaris, 7: Pseudomonas aeruginosa, 8: Corynebacterium xerosis, 9: Mycobacterium smegmatis, 10: Aeromonas hydrophila, 11: Bacillus
subtilis, 12: Candida albicans, 13: Saccharomyces cerevisiae, 14: Kluyveromyces fragilis, 15: Rhodotorula rubra
(–): no inhibition zone
Table 2: Inhibitory activity of methanolic extracts from Hypericum species in the disc diffusion assay
Extracts/standards Dose (mg/disc) Diameter of inhibition zone (mm)
1a 2 3 4 5 6 7 8
H. rupestre 1.25 – – – – – – – –
Aqueous fraction 2.50 – – – – – – – –
3.75 – – – – – – – –
H. rupestre 1.25 12 12 13 11 12 14 13 11
BuOH fraction 2.50 10 13 12 12 10 13 15 12
3.75 13 13 14 12 13 16 16 12
H. rupestre 1.25 14 13 13 14 13 16 14 12
CHCl3 fraction 2.50 13 10 13 11 11 15 15 12
3.75 15 14 13 11 11 20 16 12
H. vacciniifolium 1.25 – – – – – – – –
Aqueous fraction 2.50 – – – – – – – –
3.75 – – – – – – – –
H. vacciniifolium 1.25 – – – – – – – –
BuOH fraction 2.50 – – – – – – – –
3.75 – – – – – – – –
H. vacciniifolium 1.25 11 10 13 12 12 14 12 12
CHCl3 fraction 2.50 13 12 13 10 14 16 13 12
3.75 13 12 13 13 13 16 14 12
H. imbricatum 1.25 – – – – – – – –
Aqueous fraction 2.50 – – – – – – – –
3.75 – – – – – – – –
H. imbricatum 1.25 12 12 12 14 13 16 14 12
BuOH fraction 2.50 13 15 15 14 14 16 15 12
3.75 14 16 15 15 14 16 16 13
H. imbricatum 1.25 16 13 13 14 14 17 14 12
CHCl3 fraction 2.50 14 13 13 12 14 18 15 13
3.75 14 13 13 13 14 20 16 13
P10                                      10 units 13 8 10 14 15 10 36 15
SAM20 10µg 16 10 16 12 21 12 32 16
CTX30 30µg 12 54 18 14 11 16 32 22
VA30 30µg 13 10 20 18 20 26 34 22
OFX5 5µg 24 44 28 30 32 30 28 24
TE30 30µg 26 34 26 25 24 28 22 26
a 1: Staphylococcus aureus, 2: Micrococcus luteus, 3: Bordetella bronchiseptica, 4: Corynebacterium xerosis, 5: Mycobacterium smegmatis,
6: Bacillus subtilis, 7: Aeromonas hydrophila, 8: Pseudomonas aeruginosa
P10: Penicillin G, SAM20: Ampicillin, CTX30: Cefotaxime, V30: Vancomycin, OFX 5: Oflaxacin, TE30: Tetracyclin, (–): no inhibition zone
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